Screening for regenerative therapy responders in heart failure

Risk of outcome variability challenges therapeutic innovation. Selection of the most suitable candidates is predicated on reliable response indicators. Especially for emergent regenerative biotherapies, determinants separating success from failure in achieving disease rescue remain largely unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Satsuki, Jeon, Ryounghoon, Garmany, Armin, Behfar, Atta, Terzic, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252977/
https://www.ncbi.nlm.nih.gov/pubmed/34169733
http://dx.doi.org/10.2217/bmm-2020-0683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252977/
https://www.ncbi.nlm.nih.gov/pubmed/34169733
http://dx.doi.org/10.2217/bmm-2020-0683

Ejemplares similares